# Alleles, zygosity and copy state

Source: https://onco.cc/terms/alleles-and-zygosity/  
OnCo record `alleles-and-zygosity` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An allele is a sequence version at a genomic location. Which versions are present and how many DNA copies exist are separate questions.

## Summary

At a diploid location, heterozygous means that the two copies differ in the feature being considered; homozygous means they match. Hemizygous describes a single copy in the specified context. Tumor gains, losses and genome doubling can make a two-copy model inadequate. Loss of heterozygosity means loss of previously different allelic information; it can accompany a deletion or occur while total copy count remains unchanged. Total copy number alone cannot identify which allele was retained.

## Fields

- Kind: Term
- Last checked: 2026-11-13
- Also known as: allele; zygosity; heterozygous; homozygous; hemizygous; allelic phase

## Notes

- Variant allele frequency counts supporting reads or molecules under the assay’s definition. Purity, local copy state, subclonal mixtures and method affect it; it is not directly a cancer-cell percentage or a zygosity call. Phase asks whether specified variants share a DNA copy, a further question that a gene-name match does not answer.
- Biallelic inactivation concerns whether either parental contribution still supplies useful function in the relevant cancer-cell population, rather than simply counting two physical DNA copies or two events somewhere in a tissue. A damaging change plus loss of the other contribution can support it, but phasing, allele-specific copy state, consequence and cell mixture matter. High VAF alone cannot establish this state. Nguyen and colleagues' pan-cancer analysis associated particular biallelic repair-gene alterations with genomic damage patterns; that association does not make every variant in every repair gene functionally equivalent or establish present drug sensitivity.
- A haplotype groups linked sequence variants on a chromosome that tend to be inherited together. Phasing assigns variants to chromosome copies; that is different from counting carrier cancer cells. Labels A and B distinguish sequence versions without grading either as harmful or harmless. In a fictional set of 100 cancer cells, two variants each present in forty cells could occupy the same forty or separate groups of forty. The two individual fractions do not reveal their overlap. Joint sequence or cell-resolved evidence addresses co-occurrence, with its own sampling limits. Neither shared prevalence nor physical phase alone establishes a variant's functional importance.

## Sources

- NHGRI: Allele: https://www.genome.gov/genetics-glossary/Allele
- NHGRI: Heterozygous: https://www.genome.gov/genetics-glossary/Heterozygous
- NHGRI: Homozygous: https://www.genome.gov/genetics-glossary/Homozygous
- Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.: https://pubmed.ncbi.nlm.nih.gov/34731645/
- Absolute quantification of somatic DNA alterations in human cancer.: https://pubmed.ncbi.nlm.nih.gov/22544022/
- Pan-cancer landscape of homologous recombination deficiency (2020): https://pubmed.ncbi.nlm.nih.gov/33149131/
- NHGRI: haplotype: https://www.genome.gov/genetics-glossary/Haplotype
- Absolute quantification of somatic DNA alterations in human cancer (Nature biotechnology 2012): https://doi.org/10.1038/nbt.2203
- PyClone: statistical inference of clonal population structure in cancer (Nature methods 2014): https://doi.org/10.1038/nmeth.2883

## Connected records

- terms: [Copy number alteration (CNA)](https://onco.cc/terms/copy-number-variation-term/), [Gene amplification and copy-number change](https://onco.cc/terms/gene-amplification/), [Genome-wide loss of heterozygosity (gLOH)](https://onco.cc/terms/genome-wide-loss-of-heterozygosity/), [Germline vs somatic mutations](https://onco.cc/terms/germline-vs-somatic/), [Mutation](https://onco.cc/terms/mutation/), [Variant allele frequency (VAF)](https://onco.cc/terms/vaf/)

---
JSON: https://onco.cc/api/v1/entities/alleles-and-zygosity.json